Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that there's a need for a new conference to establish stricter guidelines for diagnosing Polycystic Ovary Syndrome (PCOS).

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

PCOS is likely inherited in families, increasing risk for first-degree relatives.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Women with acne often have PCOS.

SPIOMET therapy may be a promising alternative to oral contraceptives for treating adolescent PCOS.

Finasteride can cause depression and suicidal thoughts; safer alternatives are recommended.

Polymenorrhoea should be included in PCOS diagnostic criteria due to similar metabolic issues.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Hair microscopy is useful for diagnosing certain hair loss conditions but has limitations and must be interpreted carefully.